← Open Payments lookup

SHUKRI MAHALEY: Open Payments

NPI 1821721556 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$671 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $215 · 2025 $671

Food & beverage: $572Education: $99
CompanyPaymentsAmount
Janssen Biotech, Inc.9$340
GENZYME CORPORATION2$157
Takeda Pharmaceuticals U.S.A., Inc.3$75
Adaptive Biotechnologies Corporation1$32
BeOne Medicines USA, Inc.1$29
Karyopharm Therapeutics Inc.1$24
Tempus AI, Inc1$15

Products named: SARCLISA, CARVYKTI, DARZALEX, TECVAYLI, NINLARO, clonoSEQ, TALVEY, BRUKINSA.

Industry payments across TX — which companies pay providers there.